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Langerhans cell histiocytosis diagnosed in an elderly patient*
Histiocitose de células de Langerhans diagnosticada em um paciente de idade avançada
Josie Naomi Iyeyasu1, Ana Carolina Marcos Vaz2, Fabiano Reis3, João Altemani4, Luciano
de Souza Queiroz5, Keila Monteiro de Carvalho6
Langerhans cell histiocytosis is a rare disease characterized by proliferation of Langerhans cells. We report a case of
Langerhans cell histiocytosis in a 63-year-old patient, who presented an expansile periorbital lesion as the first symptom,
in whom computed tomography revealed characteristic lung commitment of the disease. The case management, as
well as radiological findings and outcomes are described.
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A histiocitose de células de Langerhans é uma doença rara caracterizada proliferação de células de Langerhans. Neste
artigo descrevemos um caso de histiocitose de células de Langerhans em um paciente de 63 anos, com uma lesão
expansiva periorbital como primeiro sintoma e cuja tomografia computadorizada revelou acometimento pulmonar ca-
racterístico da doença. A condução do caso, os achados radiológicos e os resultados são apresentados.
Unitermos: Histiocitose; Células de Langerhans; Órbita.
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CASE REPORT
Immuno-histochemical analysis was
positive for CD1a, CD 68, HAM56 and S-
100 in the neoplastic cells, negative for
HMB45, AE1, AE3, CD20, CD3, and posi-
tive for KI67 in 5–10% of the nuclei, cor-
roborating the diagnostic hypothesis of
Langerhans cell histiocytosis (Figure 3).
Then, the patient underwent further in-
vestigation to determine the presence of ad-
ditional foci of histiocytosis which demon-
strated a lesion in the fifth left coastal arch
and the pulmonary involvement typically
observed in cases of histiocytosis (Figure
4). The patient underwent hematological
follow-up and was submitted to two cycles
of chemotherapy with vimblastine, etopo-
side and prednisone, and progressed to
death in February 2012 because of compli-
cations resulting from his lung disease.
DISCUSSION
Langerhans cell histiocytosis is a rare
disease (incidence of 2–5 cases per mil-
lion)(1) characterized by proliferation of
Langerhans cells(2), most commonly affect-
ing male children in the age range between
one and three years(1).
The etiology of this disease still remains
unknown. It is believed that the disease is
consequence of an immunological deregu-
ing his imaging studies and the whole case
progression. At the end, the authors also
present a brief review of the literature on
the disease.
CASE REPORT
The present report describes the case of
a male, 63-year-old patient complaining of
proptosis of his right eye for six months.
Previous personal history: smoking and
alcohol use. The screening for infecto-con-
tagious diseases was negative.
Physical examination did not present
any other finding, except the right-sided
proptosis itself. Skull computed tomogra-
phy (Figure 1) revealed a lesion affecting
the lateral wall of the orbit (with bone de-
struction) and the right intraorbital region,
externally extending towards the perizygo-
matic region. Right-sided ocular globe
proptosis and invasion of the correspond-
ing lateral extrinsic orbital muscle were
observed. Then, the patient was submitted
to complete exeresis of the lesion.
Histopathological study revealed prolif-
eration of abundant macrophages (histio-
cytes) with epithelioid cells and multi-
nucleated gigantocytes with some figures
of mitosis compatible with Langerhans cell
histiocytosis (Figure 2).
INTRODUCTION
Langerhans cell histiocytosis is a rare
disease that normally affects children, in-
volving different parts of the body. Its di-
agnosis is based on histological and
immuno-histochemical studies of the le-
sions. The treatment depends on the form
of disease. The present report is aimed at
describing the case of a 63-year-old patient
affected by the disease, as well as present-
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Figure 1. Contrast-enhanced axial computed tomography of skull. Intraorbital expansile lesion extending toward the intra- and extraconal spaces, extracranial
soft tissues and bone erosion of the lateral wall (zygomatic bone and major sphenoid wing) of the right orbit.
Figure 2. Hematoxylin eosin staining demonstrates fagocytosis of hemosid-
erin by Langerhans cells recognizable by their irregular nuclei with a round or
elongated contour, frequently with cleavage and indentation, loose and well-
distributed cromatin.
Figure 3. Immuno-histochemical study demonstrates positivity for CD1a with
a membranous pattern, which is a sine qua non condition for Langerhans cell
diagnosis.
lation resulting in excessive production of
cytokines and prostaglandins, which cause
injury to several organs(1).
The disease may affect either single or
multiple organs. The clinical presentation
depends on the dysfunction degree and on
the involved organs(1) and the main com-
plications include hypophyseal dysfunc-
tion, particularly diabetes insipidus(3), and
neurodegenerative diseases(4).
The most common ophthalmological
manifestation is the presence of a solitary
bone lesion in the orbit(5), which, likewise
the presence of lesions in the mastoid and
temporal bones(6), is considered as a risk
factor for the onset of complications in the
central nervous system (CNS)(7).
Langerhans cell histiocytosis, particu-
larly in its disseminated presentation, may
be associated with other conditions such as
leukemia, Hodgkin’s and non Hodgkin’s
lymphoma, history of neonatal infection,
exposure to solvents, thyroid diseases, in-
fectious diseases (adenovirus, parvovirus,
Epstein-Barr virus, cytomegalovirus, HIV
and HTLV) and smoking(1), like it may have
occurred in the present case.
The imaging method of choice to assess
the CNS is magnetic resonance imaging for
its highest sensitivity in the detection of le-
sions notwithstanding the lack of a charac-
teristic radiological pattern of the disease(3).
The diagnosis of Langerhans cell histio-
cytosis can be made either by means of
histological analysis of the lesions (pre-
sumed diagnosis) or by immuno-his-
tochemical analysis. At optical microscopy,
monoclonal neoplastic infiltrate of Langer-
hans cells is observed with a lobulated
nucleus of thin chromatin and moderately
abundant eosinophilic cytoplasm with
some nuclear atypias and variable mytotic
activity(3). On the other hand, immuno-his-
tochemical study reveals the presence of
Birbeck granules, positivity for S-100 and
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CD1a (representing diagnostic certainty)(1),
as in the present case.
Local intervention is the treatment for
Langerhans cell histiocytosis(6) in cases of
a single lesion. Systemic treatment is re-
served for cases of incomplete response to
treatment, lesion reactivation or onset of
other lesions(7), and chemotherapy is the
gold standard(2), as observed in the present
case.
The prognosis depends of the extent of
the disease: patients with focal disease typi-
cally have a good prognosis, while patients
with disseminated disease and those with
involvement of the central nervous system
present a worse prognosis(6).
Thus, the authors conclude that Langer-
hans cell histiocytosis is a rare and severe
disease which may affect several organs.
Therefore, such disease must be included
in the list of differential diagnosis for pa-
tients with proptosis, since orbital involve-
ment indicates a probable CNS compro-
mise, i.e. worse prognosis. The authors
consider the present case as being relevant,
since it illustrates well the unfavorable
natural progression of the disease, even
with appropriate treatment, thus serving to
emphasize the importance of an early diag-
nosis. Additionally, the present case was
rare, since the disease onset occurred in an
elderly patient, while the onset in the child-
hood is most frequent. Also, it should be
observed that involvement of the orbit, like
in the present case, is seldom found.
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